Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species
Details for Australian Patent Application No. 2003293607 (hide)
International Classifications
Event Publications
22 April 2004 Complete Application Filed
Priority application(s): PCT/EP03/03096 25.03.03 EP
18 November 2004 Application Open to Public Inspection
Published as AU-B-2003293607
3 December 2009 Application Accepted
Published as AU-B-2003293607
28 January 2010 Amendment Made
The nature of the amendment is: Amend the applicant name from Vasopharm Biotech GmbH to Vasopharm GmbH
1 April 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser